SG11202001140UA - Adiponectin peptidomimetics for treating ocular disorders - Google Patents
Adiponectin peptidomimetics for treating ocular disordersInfo
- Publication number
- SG11202001140UA SG11202001140UA SG11202001140UA SG11202001140UA SG11202001140UA SG 11202001140U A SG11202001140U A SG 11202001140UA SG 11202001140U A SG11202001140U A SG 11202001140UA SG 11202001140U A SG11202001140U A SG 11202001140UA SG 11202001140U A SG11202001140U A SG 11202001140UA
- Authority
- SG
- Singapore
- Prior art keywords
- ocular disorders
- treating ocular
- adiponectin peptidomimetics
- adiponectin
- peptidomimetics
- Prior art date
Links
- 102000011690 Adiponectin Human genes 0.000 title 1
- 108010076365 Adiponectin Proteins 0.000 title 1
- 208000022873 Ocular disease Diseases 0.000 title 1
- 239000000816 peptidomimetic Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562156127P | 2015-05-01 | 2015-05-01 | |
| US15/676,968 US10537608B2 (en) | 2015-05-01 | 2017-08-14 | Adiponectin peptidomimetics for treating ocular disorders |
| PCT/US2018/045527 WO2019036223A1 (en) | 2015-05-01 | 2018-08-07 | PEPTIDOMIMETICS OF ADIPONECTIN FOR THE TREATMENT OF OCULAR DISORDERS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202001140UA true SG11202001140UA (en) | 2020-03-30 |
Family
ID=57218292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202001140UA SG11202001140UA (en) | 2015-05-01 | 2018-08-07 | Adiponectin peptidomimetics for treating ocular disorders |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US10987401B2 (https=) |
| EP (3) | EP4014985A1 (https=) |
| JP (1) | JP7245649B2 (https=) |
| KR (2) | KR20170141692A (https=) |
| CN (3) | CN115919996A (https=) |
| AU (3) | AU2016257724B2 (https=) |
| CA (3) | CA3191203A1 (https=) |
| DK (1) | DK3288577T3 (https=) |
| ES (1) | ES2903448T3 (https=) |
| IL (1) | IL272449A (https=) |
| SG (1) | SG11202001140UA (https=) |
| WO (2) | WO2016179007A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115919996A (zh) | 2015-05-01 | 2023-04-07 | 雅利斯塔制药公司 | 用于治疗眼科疾病的脂联素拟肽 |
| WO2018165218A1 (en) * | 2017-03-09 | 2018-09-13 | Allysta Pharmaceuticals, Inc | Peptides for dry eye disease |
| CN107149676A (zh) * | 2017-05-05 | 2017-09-12 | 杨硕 | 脂联素和脂联素/胰岛素混合液在改善及治疗眼表角膜上皮及神经损伤中的应用 |
| WO2019061491A1 (en) * | 2017-09-30 | 2019-04-04 | Pro Sunfun Biotech Research And Development Co., Ltd. | PEPTIDE FOR OCULAR CARE, COMPOSITION AND METHOD OF USE THEREOF |
| CN109912685B (zh) * | 2017-12-13 | 2022-05-06 | 三凡生技研发股份有限公司 | 眼睛保护胜肽及其组合物及使用该胜肽的用途 |
| CN112165954A (zh) * | 2018-03-23 | 2021-01-01 | 阿奇生物外科有限公司 | 用于治疗眼病的sap和拟肽 |
| JP7688471B2 (ja) * | 2018-10-24 | 2025-06-04 | アリスタ ファーマスーティカルス インク． | アディポネクチンペプチド模倣組成物 |
| JP7699426B2 (ja) * | 2018-11-30 | 2025-06-27 | ロート製薬株式会社 | 光線による障害からの細胞保護用眼科組成物 |
| US11229549B2 (en) * | 2019-09-18 | 2022-01-25 | Vance M. Thompson | Tear transplantation and multi-part contact lens with absorbent portion |
| JP7419499B2 (ja) | 2019-09-18 | 2024-01-22 | アルコン インク． | 湿式充填のソフトヒドロゲル眼用インサート |
| US11213551B1 (en) | 2021-04-05 | 2022-01-04 | Korb Research, Llc. | Ocular treatment compositions and methods of use thereof |
| WO2023069549A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| WO2023069255A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| WO2023107796A1 (en) * | 2021-12-11 | 2023-06-15 | The Regents Of The University Of California | Ophthalmic formulations for macular degeneration |
| WO2024180472A1 (en) | 2023-02-28 | 2024-09-06 | Alcon Inc. | Ocular inserts |
| KR102609115B1 (ko) * | 2023-06-08 | 2023-12-05 | 주식회사 엔큐라젠 | 펩타이드를 포함하는 안구 질환의 치료용 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| DE4437604A1 (de) | 1994-10-21 | 1996-04-25 | Basf Ag | Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| EE05214B1 (et) | 1998-04-28 | 2009-10-15 | Applied Research Systems ARS Holding N.V. | Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon |
| GB9814527D0 (en) | 1998-07-03 | 1998-09-02 | Cyclacel Ltd | Delivery system |
| CA2473781A1 (en) * | 2002-01-18 | 2003-07-31 | Protemix Corporation Limited | Glycoisoforms of adiponectin and uses thereof |
| MX2007013430A (es) * | 2005-04-29 | 2008-03-19 | Univ California | Peptidos y peptidos mimeticos para tratar patologias caracterizadas por una respuesta inflamatoria. |
| WO2012142142A2 (en) * | 2011-04-12 | 2012-10-18 | Temple University - Of The Commonwealth System Higher Education | Adiponectin receptor agonists and methods of use |
| KR101438744B1 (ko) * | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| RU2652063C2 (ru) * | 2012-10-26 | 2018-04-24 | Форсайт Вижн5, Инк. | Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу |
| CN115919996A (zh) * | 2015-05-01 | 2023-04-07 | 雅利斯塔制药公司 | 用于治疗眼科疾病的脂联素拟肽 |
-
2016
- 2016-04-29 CN CN202210970186.8A patent/CN115919996A/zh active Pending
- 2016-04-29 DK DK16789840.2T patent/DK3288577T3/da active
- 2016-04-29 EP EP21204663.5A patent/EP4014985A1/en not_active Withdrawn
- 2016-04-29 EP EP16789840.2A patent/EP3288577B1/en active Active
- 2016-04-29 CA CA3191203A patent/CA3191203A1/en active Pending
- 2016-04-29 AU AU2016257724A patent/AU2016257724B2/en active Active
- 2016-04-29 KR KR1020177031104A patent/KR20170141692A/ko not_active Ceased
- 2016-04-29 US US15/571,039 patent/US10987401B2/en active Active
- 2016-04-29 JP JP2018508628A patent/JP7245649B2/ja active Active
- 2016-04-29 CA CA2981822A patent/CA2981822C/en active Active
- 2016-04-29 WO PCT/US2016/030142 patent/WO2016179007A1/en not_active Ceased
- 2016-04-29 ES ES16789840T patent/ES2903448T3/es active Active
- 2016-04-29 CN CN201680023972.XA patent/CN107530396B/zh active Active
-
2017
- 2017-08-14 US US15/676,968 patent/US10537608B2/en active Active
-
2018
- 2018-08-07 CA CA3071670A patent/CA3071670A1/en active Pending
- 2018-08-07 EP EP18845611.5A patent/EP3668530A4/en not_active Withdrawn
- 2018-08-07 AU AU2018318008A patent/AU2018318008A1/en not_active Abandoned
- 2018-08-07 WO PCT/US2018/045527 patent/WO2019036223A1/en not_active Ceased
- 2018-08-07 CN CN201880052451.6A patent/CN111032070A/zh active Pending
- 2018-08-07 KR KR1020207007015A patent/KR20200039749A/ko not_active Ceased
- 2018-08-07 SG SG11202001140UA patent/SG11202001140UA/en unknown
-
2019
- 2019-11-24 US US16/693,355 patent/US11273197B2/en active Active
-
2020
- 2020-02-04 IL IL272449A patent/IL272449A/en unknown
-
2021
- 2021-01-11 US US17/146,397 patent/US11464825B2/en active Active
- 2021-05-20 AU AU2021203254A patent/AU2021203254A1/en not_active Abandoned
-
2022
- 2022-02-24 US US17/680,181 patent/US20220331393A1/en not_active Abandoned
- 2022-10-04 US US17/937,849 patent/US20230074446A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272449A (en) | Adiponectin peptide deletions for the treatment of ocular disorders | |
| IL279308A (en) | Methods for the treatment of heptidine-mediated disorders | |
| IL285151B1 (en) | Methods for the treatment of fgf21-related disorders | |
| IL265497B (en) | Methods for treating eye diseases | |
| ZA201705673B (en) | Methods for treating skin | |
| PT3261640T (pt) | Agonistas de 5ht para tratamento de distúrbios de epilepsia | |
| GB2544294B (en) | Goggles for snowsports | |
| ZA201700416B (en) | Methods for treating or preventing ophthalmological conditions | |
| IL254393A0 (en) | Methods for treating diseases associated with pathological changes in protein | |
| HUE049518T2 (hu) | Készítmények és eljárások a szem megbetegedéseinek kezelésére és diagnosztizálására | |
| GB201512733D0 (en) | Therapeutic agents for treating conditions associated with elevated GDF15 | |
| PT3119911T (pt) | Compostos para uso no tratamento da doença de alzheimer em pacientes apoe4+/+ | |
| PL3145511T3 (pl) | Kompozycja do leczenia oka | |
| SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
| GB201701404D0 (en) | Therapies for treating inflammatory disorders | |
| HUE062406T2 (hu) | Készítmények szemészeti állapotok kezelésére | |
| PT3420084T (pt) | Nova abordagem para tratamento de disfunções inflamatórias | |
| HK1261774A1 (en) | Methods for treating eye disorders | |
| EP3177316A4 (en) | Method for preventing or treating ocular disorders | |
| GB201602011D0 (en) | Treating skin disorders | |
| GB201701933D0 (en) | New methods for the treatment of hyperglycaemia | |
| GB201521543D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201513993D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201513345D0 (en) | Methods for the treatment of Inflammatory disorders | |
| GB201507113D0 (en) | Methods for the treatment of inflammatory disorders |